(5S,6R,E)-methyl 5,6-dihydroxy-8-(1-((S)-1-hydroxyhexyl)isoquinolin-3-yl)oct-7-enoate

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 英文名称: (5S,6R,E)-methyl 5,6-dihydroxy-8-(1-((S)-1-hydroxyhexyl)isoquinolin-3-yl)oct-7-enoate
• 英文别名: methyl (E,5S,6R)-5,6-dihydroxy-8-[1-[(1S)-1-hydroxyhexyl]isoquinolin-3-yl]oct-7-enoate
• 化学式: C₂₄H₃₃NO₅
• 分子量: 415.53
• InChiKey: QKEGRPVWYHXLBX-SZBXWFPRSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  30
• 可旋转键数：
  13
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  99.9
• 氢给体数：
  3
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  (5S,6R,E)-methyl 5,6-bis((tert-butyldimethylsilyl)oxy)-8-(1-hexanoylisoquinolin-3-yl)oct-7-enoate 在 [(1S,2S)-N-(p-toluensulfonyl)-1,2-diphenylethanediamine](p-cymene)ruthenium (I) 、 甲酸 、 四丁基氟化铵 、 三乙胺 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 为溶剂， 反应 40.0h， 生成 (5S,6R,E)-methyl 5,6-dihydroxy-8-(1-((S)-1-hydroxyhexyl)isoquinolin-3-yl)oct-7-enoate
  参考文献：
  名称：

  [EN] HETEROCYCLIC LIPOXIN ANALOGS AND USES THEREOF
  [FR] ANALOGUES DE LIPXON HÉTÉROCYCLIQUES ET LEURS UTILISATIONS

  摘要：

  公开号：

  WO2018033642A9

文献信息

• Heterocyclic lipoxin analogs and uses thereof
  申请人：University College Dublin, National University of Ireland, Dublin

  公开号：US11161824B2

  公开（公告）日：2021-11-02

  The present invention relates to a compound of formula (I): wherein L is an optionally substituted heterocyclic group excluding unsubstituted monocyclic pyridine groups; wherein a is 0, 1 or 2; wherein R1 is H or with R2 is a bond; wherein R2 is an optionally substituted alkoxy or aryloxy group, or with R1 forms a bond; wherein R3 is an optionally substituted alkyl group; and wherein R4 is CH2, CMe2 or O. Such compounds may be used in the treatment or prophylaxis of a disease or condition in which inhibition of acute inflammation and/or promotion of its resolution and/or suppression of fibrosis.

  本发明涉及式(I)化合物：其中L为任选取代的杂环基团，不包括未取代的单环吡啶基团；其中a为0、1或2；其中R1为H或与R2为键；其中R2为任选取代的烷氧基或芳氧基，或与R1形成键；其中R3为任选取代的烷基；以及其中R4为CH2、CMe2或O。此类化合物可用于抑制急性炎症和/或促进炎症消退和/或抑制纤维化的疾病或病症的治疗或预防。
• Heterocyclic Lipoxin Analogs and Uses Thereof
  申请人：University College Dublin

  公开号：US20210053927A1

  公开（公告）日：2021-02-25

  The present invention relates to a compound of formula (I): wherein L is an optionally substituted heterocyclic group excluding unsubstituted monocyclic pyridine groups; wherein a is 0, 1 or 2; wherein R 1 is H or with R 2 is a bond; wherein R 2 is an optionally substituted alkoxy or aryloxy group, or with R 1 forms a bond; wherein R 3 is an optionally substituted alkyl group; and wherein R 4 is CH 2 , CMe 2 or O. Such compounds may be used in the treatment or prophylaxis of a disease or condition in which inhibition of acute inflammation and/or promotion of its resolution and/or suppression of fibrosis.
• [EN] HETEROCYCLIC LIPXON ANALOGS AND USES THEROF<br/>[FR] ANALOGUES DE LIPXON HÉTÉROCYCLIQUES ET LEURS UTILISATIONS
  申请人：UNIV DUBLIN

  公开号：WO2018033642A1

  公开（公告）日：2018-02-22

  The present invention relates to a compound of formula (I): wherein L is an optionally substituted heterocyclic group excluding unsubstituted monocyclic pyridine groups; wherein a is 0, 1 or 2; wherein R1 is H or with R2 is a bond; wherein R2 is an optionally substituted alkoxy or aryloxy group, or with R1 forms a bond; wherein R3 is an optionally substituted alkyl group; and wherein R4 is CH2, CMe2 or O. Such compounds may be used in the treatment or prophylaxis of a disease or condition in which inhibition of acute inflammation and/or promotion of its resolution and/or suppression of fibrosis.